News

Novartis has halted production of its two commercial radioligand treatments for cancer care just weeks after the FDA approved them. Novartis confirmed on May 5th that production of Lutathera, a neuroendocrine tumour medication, and Pluvicto, a newly approved prostate cancer...

The US Food and Drug Administration recently announced that the Johnson & Johnson/Janssen COVID-19 vaccine's urgent use permit will be restricted to people 18 or older for whom other vaccines are really not suitable or available, as well as...

Multiply Labs is equipping itself with two additional pieces of industry-leading tech in its quest to automate manual elements of the cell therapy production process. The new kit arrives little over a year after the robotics company reported a...

According to a trio of prominent US Food and Drug Administration experts, the US may need to update its COVID-19 vaccines every year, and "a new normal" may comprise a yearly vaccine alongside a seasonal flu shot. The advent of...

The question is whether to boost or not to boost. The answer is a resounding yes, as per officials at mRNA expert Moderna. Moderna's chief medical officer, Paul Burton, M.D., Ph.D., stated that the SARS-CoV-2 omicron variant's meteoric rise...

Astorg and International Chemical Investors Group announce that they have signed a binding agreement whereby Astorg will acquire CordenPharma (“CordenPharma” or the “Company”), a global leading pharmaceutical CDMO (Contract Development & Manufacturing Organisation) with highly differentiated capabilities in Active...

The Government of India recently announced that the pharmaceutical sector had its best-ever export performance in 2021-22, with a phenomenal increase of about $10 billion in just eight years. Since 2013-14, the country's pharmaceutical sector has grown by 103%, from...